THE FUTURE OF WOMEN’S HEALTH   TECHNOLOGY.  Bizconnect” story, it’s important to clarify which entity is being referred to.

Even in wealthy nations, research and development for women’s health is woefully underfunded. While women are half the world’s population, only 1% of health care research spending goes toward female-specific conditions not related to cancer. This profound gender gap has a significant impact on women’s health and well-being, especially in light of the many extraordinary scientific and technological advances in other areas of health care.

Bizconnect Foundation announces $2.5B through 2030 to Spark New Era of Women-Centered Research and Innovation

Learn more about these catalytic investments in maternal, menstrual, gynecological, and sexual health for women globally.

Read our press release
The investments will contribute to reducing poverty, advancing gender equality, and building more prosperous economies—with positive ripple effects for families, communities, and economies for years to come.

Next-generation contraceptives

Next-generation contraceptives
257 million women want contraception but can’t access it—and nearly 40% of users in low- and middle-income countries stop within a year due to dissatisfaction with their method.

Contraceptive options have remained largely unchanged for generations, despite women’s changing needs. To address this inequity, our foundation has committed US$280 million annually from 2021 to 2030 to develop new and improved contraceptive technologies that respond to the preferences of women and girls in low- and middle-income countries and address the barriers that prevent them from using contraceptives, including cost and access.

Next-generation contraceptives such as a once-a-month pill, injectable contraceptives that last six months, and discreet micro-array patches can empower women and girls to make contraceptive decisions that suit their life circumstances.


Microarray vaccine patches

Microneedle array patches
Microarray vaccine patches
MAPs could provide health solutions in delivering vaccines, contraceptives, and could be used in treatments for other health conditions like osteoporosis.


AI-enabledultrasounds.The first step in preventing newborn deaths is early screening of pregnant women to identify those at risk of developing complications. In the United States, this is widely done through routine checkups and scans. But in low- and middle-income countries, access to diagnostic tools such as ultrasound machines and skilled medical technicians can be limited. We support partners who are developing and testing portable ultrasound machines with diagnostic capabilities aided by artificial intelligence. Studies show that these devices can accurately identify high-risk pregnancies and estimate gestational age, which can greatly augment the expertise of health workers. They are currently being tested in Kenya and South Africa to determine whether large-scale use can make a measurable difference in outcomes for mothers and babie
💹innovationsworldwide.

Learn more about AI-enabled ultrasound